Medipharm Labs Corp Cash Flow Reinvestment Rate

Latest as of December 2025: 0.23x

Medipharm Labs Corp cash flow reinvestment rate. Medipharm Labs Corp (LABS) has a Cash Flow Reinvestment Rate of 0.23x as of December 2025, reinvesting CA$100.00K (capex CA$100.00K ) from operating cash flow of CA$435.00K. Explore LABS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.23x
(Capex + Investments) / Operating CF

Total Reinvested

CA$100.00K
Capex + Investments

Operating Cash Flow

CA$435.00K
CAD

Capital Expenditures

CA$100.00K
CAD

Cash Flow Reinvestment Rate of Medipharm Labs Corp (2017–2017)

Cash flow reinvestment rate of Medipharm Labs Corp from 2017 to 2017. Historical reinvestment intensity for Medipharm Labs Corp across 1 annual periods. Explore LABS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Medipharm Labs Corp Cash Flow Reinvestment Rate by Year (2017–2017)

Medipharm Labs Corp cash flow reinvestment rate by year from 2017 to 2017. Year-by-year capital reinvestment analysis for Medipharm Labs Corp. For the full cash flow conversion analysis, see LABS cash flow conversion.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2017 13.22x CA$2.19 Million CA$166.00K CA$2.14 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow